サリドロシドは,エタノール曝露によって悪化した糖尿病マウスの肝臓のインスリン抵抗性を軽減する
Qin Xiang1, Yue Zhang1, Shiqi Chen1
1Hubei Key Laboratory of Wudang Local Chinese Medicine Research, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, Hubei, China; Institute of Wudang Traditional Chinese Medicine, Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
International immunopharmacology
|January 1, 2026
まとめ
No abstract available in PubMed .
関連する概念動画
Oral Hypoglycemic Agents: Biguanides and Glitazones
559
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
559
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
501
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
501


